CG Insider Filing: CFO's 2,992 Dividend-Equivalent Units Reported
Rhea-AI Filing Summary
John C. Redett, Chief Financial Officer of The Carlyle Group Inc. (CG), received 2,992 common stock units as dividend equivalents tied to previously granted time-vesting restricted stock units. The transaction is reported as an acquisition on 08/28/2025 at a $0 price, reflecting accrual of dividend equivalent units in connection with the issuer's quarterly dividend.
Following the award, Mr. Redett beneficially owns 1,096,386 shares. The dividend equivalent units will vest on the same schedule and under the same terms as the underlying restricted stock unit awards. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Redett on 08/29/2025.
Positive
- Transparent disclosure of insider equity changes following the company's dividend, supporting governance and market transparency
- Units vest with existing RSU schedule, indicating alignment with previously approved compensation terms rather than an ad hoc award
Negative
- None.
Insights
TL;DR: Routine executive compensation accrual; aligns with existing RSU vesting schedules and dividend policy.
The reported issuance of 2,992 dividend-equivalent units to the CFO is described as an accrual tied to previously granted time-vesting RSUs, not a new standalone grant. Because these units vest on the same schedule and terms as the underlying awards, the transaction reflects normal compensation mechanics following a quarterly dividend rather than discretionary additional compensation. For governance purposes this is routine disclosure that maintains transparency on insider holdings and potential dilution from long-term equity awards.
TL;DR: Immateral to valuation; small incremental increase in insider holdings with no cash consideration.
The acquisition of 2,992 units at $0 increases the CFO's beneficial ownership to 1,096,386 shares. The transaction results from dividend equivalent accruals on existing RSUs and carries no purchase price, indicating no immediate cash flow impact. Given the scale relative to the total outstanding shares implied by the reporting context, this is unlikely to be material to company valuation or near-term financials.